伦敦的AI公司Basecamp Research获得了由Singular领导的6000万美元B轮融资,并与Broad Institute合作开发可编程遗传医学. London-based AI company Basecamp Research secures $60m Series B funding led by Singular and partners with Broad Institute for programmable genetic medicine development.

总部位于伦敦的AI公司Basecamp Research在Singular领导的B轮融资中获得了6000万美元,并与麻省理工学院和哈佛大学的Broad研究所建立了合作伙伴关系. Basecamp Research, a London-based AI company, has secured $60 million in a Series B funding round led by Singular and entered a partnership with the Broad Institute of MIT and Harvard. 这一合作旨在开发创新的、可规划的遗传药物。 This collaboration aims to develop innovative programmable genetic medicines. 这笔资金将帮助基地营地加强其广泛的生物数据库和人工智能能力,最终帮助发现毒品和进行农业研究。 The funding will help Basecamp enhance its extensive biological database and AI capabilities, ultimately aiding drug discovery and agricultural research. 资金总额现在达到8 500万美元。 Total funding now reaches $85 million.